Parkinson’s disease is a progressive condition related to the degeneration of dopaminergic neurons. In essence, as the dopamine signaling system in the brain breaks down, Parkinson’s disease gets worse.
This paper highlights the endocannabinoid system as a promising target for helping with the treatment of Parkinson’s.
Here is the full scientific article if you wish to download it.
The endocannabinoid system is another signaling system that we have. As you have maybe noticed, “endocannabinoid” and “cannabidiol” (CBD) seem like related words. Cannabidiol is one of several cannabinoids.
Cannabinoids, such as CBD, that are extracted from plants, (especially Cannabis Satvia and hemp) have been seen to interact with the endocannabinoid system within our bodies. CBD, in fact, has been observed to have anti-inflammatory and anti-pain properties, to name a couple.
In this paper, the authors point out that the endocannabinoid system has recently been connected with the neurobiology of Parkinson’s. The researchers, through investigation, found that a daily dose of CBD resulted in significant effects on the individual’s daily life activities, mobility, and emotional well-being.
They do, however, mention that these results may not be due to a direct effect of CBD on Parkinson’s. This could be due to either sedative effects or antidepressant effects of CBD.
CBD Has Potential To Treat Parkinson’s
The authors conclude that there is a potential use for CBD in the treatment of Parkinson’s. However, as the patients investigated in this study were only a specific group of those with Parkinson’s disease, a lot of further research is needed before any concrete claims can be made.
Though I’d like to suggest, that if CBD doesn’t interact with other Parkinson’s medications, and increases the quality of life, mightn’t it be a good idea to offer patients daily doses, too?